Home > Healthcare > Medical Devices > Therapeutic Devices > Robotic Endoscopy Devices Market

Robotic Endoscopy Devices Market Size

  • Report ID: GMI8222
  • Published Date: Feb 2024
  • Report Format: PDF

Robotic Endoscopy Devices Market Size

Robotic Endoscopy Devices Market size was valued at around USD 2.4 billion in 2023 and is estimated to expand at 11% CAGR from 2024 to 2032, owing to the rising prevalence of gastrointestinal disorders and other chronic ailments, coupled with surging demand for minimally invasive procedures.

 

The increasing incidence of gastrointestinal disorders and other chronic illnesses, such as ulcerative colitis, irritable bowel syndrome, chronic constipation, diverticular disease, gallstones, and hemorrhoids, among others, is one of the prime factors driving the demand for robotic endoscopic devices. The rise in gastrointestinal diseases is due to various factors, including increased antibiotic usage, poor dietary choices, sedentary lifestyle, exposure to environmental toxins, and the growing proportion of aging demographics.

 

For instance, according to a study published in the Gastroenterology journal in 2020, functional gastrointestinal disorders (FGIDs) exhibit a substantial global prevalence, affecting approximately 40% of the general populace with at least one FGID. Additionally, the as per the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) conducted in 2019, states that digestive diseases constituted 2.3 billion estimated prevalent cases, resulting in 2.56 million deaths and 89 million DALYs (Disability-Adjusted Life Years) worldwide.

 

Robotic endoscopic devices are advanced medical instruments equipped with robotic technology that assist in performing endoscopic procedures. These devices are designed to enhance precision, control, and maneuverability during endoscopic examinations and interventions within the body's cavities and organs.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The robotic endoscopy devices market was valued at around USD 2.4 billion in 2023 and is expected to reach around USD 6.2 billion by 2032, driven by rising prevalence of gastrointestinal disorders and other chronic ailments.

The therapeutic segment held dominating market share in 2023 and is anticipated to reach USD 5.9 billion by 2032, driven by the surging demand for minimally invasive procedures worldwide.

North America robotic endoscopy devices industry accounted for around USD 1.5 billion in 2023 and is predicted to witness substantial growth through 2032, attributed to the prevalence of obesity and diabetes in the region.

AKTORmed GmbH, Asensus Surgical Inc., Boston Scientific Corporation, Brainlab AG, CONMED Corporation, FUJIFILM Holdings Corporation, Intuitive Surgical, Inc., Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Renishaw plc, and Richard Wolf GmbH.

Robotic Endoscopy Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 206
  • Countries covered: 22
  • Pages: 110
 Download Free Sample